.
schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.".
poll: can technology solve irish border issue after brexit? .jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies..